Skip to main content

Peer Review reports

From: Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China

Original Submission
21 Aug 2021 Submitted Original manuscript
29 Nov 2021 Reviewed Reviewer Report
11 Feb 2022 Reviewed Reviewer Report
5 Mar 2022 Author responded Author comments - Lin Fan
7 Mar 2022 Author responded Author comments - Lin Fan
Resubmission - Version 2
5 Mar 2022 Submitted Manuscript version 2
20 Mar 2022 Reviewed Reviewer Report
3 Apr 2022 Author responded Author comments - Lin Fan
Resubmission - Version 3
3 Apr 2022 Submitted Manuscript version 3
22 Apr 2022 Reviewed Reviewer Report
8 May 2022 Author responded Author comments - Lin Fan
Resubmission - Version 4
8 May 2022 Submitted Manuscript version 4
2 Jul 2022 Reviewed Reviewer Report - Alexey Filippov
9 Jul 2022 Author responded Author comments - Lin Fan
Resubmission - Version 5
9 Jul 2022 Submitted Manuscript version 5
14 Jul 2022 Reviewed Reviewer Report - Alexey Filippov
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
16 Aug 2022 Editorially accepted
29 Aug 2022 Article published 10.1186/s12879-022-07693-9

You can find further information about peer review here.

Back to article page